Abstract
We write to encourage policy debate over newborn screening for congenital adrenal hyperplasia (CAH). Classical CAH is a severe, life-threatening disease affecting about one in 15 000 liveborn infants in Australia.1 An inexpensive screening test for newborns is available, but this test is not included in the current newborn screening program in Australia.
Original language | English |
---|---|
Pages (from-to) | 107 |
Number of pages | 1 |
Journal | Medical Journal of Australia |
Volume | 192 |
Issue number | 2 |
DOIs | |
Publication status | Published - 18 Jan 2010 |